Galmed Pharmaceuticals - 11 Year Stock Price History | GLMD

Historical daily share price chart and data for Galmed Pharmaceuticals since 2014 adjusted for splits and dividends. The latest closing stock price for Galmed Pharmaceuticals as of May 16, 2025 is 1.19.
  • The all-time high Galmed Pharmaceuticals stock closing price was 3232.80 on June 13, 2018.
  • The Galmed Pharmaceuticals 52-week high stock price is 23.80, which is 1900% above the current share price.
  • The Galmed Pharmaceuticals 52-week low stock price is 1.15, which is 3.4% below the current share price.
  • The average Galmed Pharmaceuticals stock price for the last 52 weeks is 3.23.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Galmed Pharmaceuticals Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 2.0722 3.3200 3.4300 1.1900 1.1900 -62.70%
2024 4.1562 5.2764 15.1000 2.5600 3.1900 -41.58%
2023 44.5676 128.0340 162.0000 3.5316 5.4600 -93.93%
2022 149.0985 372.6000 372.6000 52.2000 90.0000 -72.53%
2021 551.1856 574.2000 972.0000 315.0000 327.6000 -41.48%
2020 807.5099 1044.0000 1231.2000 550.8000 559.8000 -46.19%
2019 1147.2871 1368.0000 1632.6000 649.8000 1040.4000 -15.37%
2018 1749.0065 1690.2000 3232.8000 907.2000 1229.4000 -25.36%
2017 1151.6585 653.4000 1677.6000 653.4000 1647.0000 160.68%
2016 833.8634 1359.0000 1377.0000 513.0000 631.8000 -53.88%
2015 1621.4723 1049.4000 2385.0000 1049.4000 1369.8000 31.21%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.002B $0.000B
Galmed Pharmaceuticals Ltd. is a clinical-stage biopharmaceutical company. It is focused on developing therapies for liver diseases and gallstones. Galmed Pharmaceuticals Ltd. is based in Tel Aviv, Israel.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $84.579B 31.73
Zoetis (ZTS) United States $71.389B 26.64
Takeda Pharmaceutical (TAK) Japan $44.547B 8.86
Daiichi Sankyo, - (DSNKY) Japan $44.407B 22.59
Sandoz Group AG (SDZNY) Switzerland $20.218B 0.00
Summit Therapeutics (SMMT) United States $17.148B 0.00
Merck (MKKGY) Germany $16.879B 12.37
United Therapeutics (UTHR) United States $13.709B 12.13
Shionogi (SGIOY) Japan $12.740B 12.76
Neurocrine Biosciences (NBIX) United States $11.903B 40.77
IPSEN (IPSEY) France $9.572B 0.00
Orion OYJ (ORINY) Finland $8.544B 23.11
Corcept Therapeutics (CORT) United States $7.779B 63.24
Stevanato Group S.p.A (STVN) Italy $7.062B 43.19
Madrigal Pharmaceuticals (MDGL) United States $6.479B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.976B 0.00
Grifols, S.A (GRFS) Spain $5.397B 0.00
Ionis Pharmaceuticals (IONS) United States $5.251B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.040B 15.33
Soleno Therapeutics (SLNO) United States $3.783B 0.00
Crinetics Pharmaceuticals (CRNX) United States $2.922B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.901B 10.16
Hypermarcas (HYPMY) Brazil $2.869B 18.88
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.351B 12.71
BioCryst Pharmaceuticals (BCRX) United States $2.136B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.054B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.728B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.682B 0.00
Guardian Pharmacy Services (GRDN) United States $1.577B 0.00
Indivior (INDV) United States $1.526B 6.47
Evotec AG (EVO) Germany $1.399B 0.00
Dyne Therapeutics (DYN) United States $1.334B 0.00
ARS Pharmaceuticals (SPRY) United States $1.198B 0.00
Ocular Therapeutix (OCUL) United States $1.142B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.101B 22.03
Collegium Pharmaceutical (COLL) United States $0.943B 5.08
Harrow (HROW) United States $0.940B 0.00
Enliven Therapeutics (ELVN) United States $0.874B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.860B 0.00
Ardelyx (ARDX) United States $0.809B 0.00
Cronos Group (CRON) Canada $0.802B 0.00
Xeris Biopharma Holdings (XERS) United States $0.749B 0.00
AleAnna (ANNA) United States $0.700B 0.00
Akebia Therapeutics (AKBA) United States $0.667B 0.00
Xencor (XNCR) United States $0.584B 0.00
KalVista Pharmaceuticals (KALV) United States $0.580B 0.00
USANA Health Sciences (USNA) United States $0.559B 12.15
Regulus Therapeutics (RGLS) United States $0.543B 0.00
Savara (SVRA) United States $0.538B 0.00
Bioventus (BVS) United States $0.537B 13.62
CytoDyn (CYDY) United States $0.505B 0.00
Elite Pharmaceuticals (ELTP) United States $0.482B 0.00
Relay Therapeutics (RLAY) United States $0.478B 0.00
Altimmune (ALT) United States $0.469B 0.00
Zevra Therapeutics (ZVRA) United States $0.461B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.457B 0.00
Siga Technologies (SIGA) United States $0.423B 8.84
Amylyx Pharmaceuticals (AMLX) United States $0.403B 0.00
Tourmaline Bio (TRML) United States $0.399B 0.00
Verve Therapeutics (VERV) United States $0.385B 0.00
Organogenesis (ORGO) United States $0.384B 0.00
Oruka Therapeutics (ORKA) United States $0.354B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.353B 9.54
Heron Therapeutics (HRTX) United States $0.285B 0.00
Nature's Sunshine Products (NATR) United States $0.270B 24.90
ProKidney (PROK) United States $0.249B 0.00
Aquestive Therapeutics (AQST) United States $0.236B 0.00
MediWound (MDWD) Israel $0.216B 0.00
OmniAb (OABI) United States $0.189B 0.00
Nanobiotix S.A (NBTX) France $0.173B 0.00
Liminatus Pharma (LIMN) $0.172B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.169B 0.00
Avita Medical (RCEL) United States $0.168B 0.00
Wellgistics Health (WGRX) United States $0.167B 0.00
Journey Medical (DERM) United States $0.164B 0.00
Esperion Therapeutics (ESPR) United States $0.154B 0.00
Inhibikase Therapeutics (IKT) United States $0.151B 0.00
4D Molecular Therapeutics (FDMT) United States $0.148B 0.00
Profound Medical (PROF) Canada $0.136B 0.00
Korro Bio (KRRO) United States $0.136B 0.00
Aclaris Therapeutics (ACRS) United States $0.132B 0.00
Aldeyra Therapeutics (ALDX) United States $0.129B 0.00
Nektar Therapeutics (NKTR) United States $0.127B 0.00
Innate Pharma SA (IPHYF) France $0.122B 0.00
Protara Therapeutics (TARA) United States $0.120B 0.00
Larimar Therapeutics (LRMR) United States $0.120B 0.00
Lyell Immunopharma (LYEL) United States $0.119B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.115B 0.00
Cassava Sciences (SAVA) United States $0.099B 0.00
VAXART, INC (VXRT) United States $0.097B 0.00
OptiNose (OPTN) United States $0.096B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.096B 0.00
Achieve Life Sciences (ACHV) Canada $0.095B 0.00
Cardiol Therapeutics (CRDL) Canada $0.094B 0.00
Lexeo Therapeutics (LXEO) United States $0.090B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.088B 0.00
Champions Oncology (CSBR) United States $0.087B 14.27
Galectin Therapeutics (GALT) United States $0.083B 0.00
Dominari Holdings (DOMH) United States $0.082B 0.00
Fractyl Health (GUTS) United States $0.081B 0.00
Arch Biopartners (ACHFF) Canada $0.080B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.078B 58.22
ESSA Pharma (EPIX) Canada $0.076B 0.00
Telomir Pharmaceuticals (TELO) United States $0.070B 0.00
Inotiv (NOTV) United States $0.070B 0.00
Pyxis Oncology (PYXS) United States $0.069B 0.00
Context Therapeutics (CNTX) United States $0.067B 0.00
Unicycive Therapeutics (UNCY) United States $0.066B 0.00
Nutriband (NTRB) United States $0.062B 0.00
Assertio Holdings (ASRT) United States $0.061B 0.00
Vivani Medical (VANI) United States $0.061B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.059B 0.00
Surrozen (SRZN) United States $0.059B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Metagenomi (MGX) United States $0.058B 0.00
Gain Therapeutics (GANX) United States $0.054B 0.00
Prelude Therapeutics (PRLD) United States $0.053B 0.00
Karyopharm Therapeutics (KPTI) United States $0.047B 0.00
Century Therapeutics (IPSC) United States $0.045B 0.00
Mural Oncology (MURA) Ireland $0.044B 0.00
PMV Pharmaceuticals (PMVP) United States $0.044B 0.00
Avalo Therapeutics (AVTX) United States $0.042B 0.00
NRx Pharmaceuticals (NRXP) United States $0.041B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.039B 0.00
SCYNEXIS (SCYX) United States $0.038B 0.00
Iterum Therapeutics (ITRM) Ireland $0.037B 0.00
ElectroCore (ECOR) United States $0.037B 0.00
Rafael Holdings (RFL) United States $0.036B 0.00
Acrivon Therapeutics (ACRV) United States $0.034B 0.00
FibroGen (FGEN) United States $0.031B 0.00
PolyPid (PYPD) Israel $0.029B 0.00
Enlivex Therapeutics (ENLV) Israel $0.024B 0.00
Tempest Therapeutics (TPST) United States $0.024B 0.00
CASI Pharmaceuticals (CASI) China $0.022B 0.00
Mannatech (MTEX) United States $0.021B 0.00
Natural Alternatives (NAII) United States $0.020B 0.00
Jupiter Neurosciences (JUNS) United States $0.020B 0.00
Lipocine (LPCN) United States $0.020B 0.00
BioVie (BIVI) United States $0.019B 0.00
DURECT (DRRX) United States $0.019B 0.00
VYNE Therapeutics (VYNE) United States $0.019B 0.00
Vivos Therapeutics (VVOS) United States $0.018B 0.00
TherapeuticsMD (TXMD) United States $0.017B 0.00
ProPhase Labs (PRPH) United States $0.017B 0.00
GlycoMimetics (GLYC) United States $0.016B 0.00
Ernexa Therapeutics (ERNA) United States $0.015B 0.00
MEI Pharma (MEIP) United States $0.014B 0.00
Relmada Therapeutics (RLMD) United States $0.014B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.013B 0.00
Cosmos Health (COSM) United States $0.012B 0.00
Scienture Holdings (SCNX) United States $0.012B 0.00
Minerva Neurosciences (NERV) United States $0.011B 1.90
BioLineRx (BLRX) Israel $0.010B 0.00
Talphera (TLPH) United States $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
Biomerica (BMRA) United States $0.009B 0.00
Plus Therapeutics (PSTV) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Phio Pharmaceuticals (PHIO) United States $0.009B 0.00
Ainos (AIMD) United States $0.008B 0.00
Citius Pharmaceuticals (CTXR) United States $0.008B 0.00
Lyra Therapeutics (LYRA) United States $0.007B 0.00
Carisma Therapeutics (CARM) United States $0.007B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
Mangoceuticals (MGRX) United States $0.007B 0.00
Indaptus Therapeutics (INDP) United States $0.007B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.006B 0.00
Traws Pharma (TRAW) United States $0.006B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.006B 0.00
Klotho Neurosciences (KLTO) United States $0.006B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Incannex Healthcare (IXHL) Australia $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Conduit Pharmaceuticals (CDT) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
PainReform (PRFX) Israel $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.001B 0.00
SHINECO (SISI) China $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.001B 0.00
Petros Pharmaceuticals (PTPI) United States $0.000B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Aditxt (ADTX) United States $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00